Moberg Pharma AB (publ) (STO: MOB)
Sweden
· Delayed Price · Currency is SEK
18.66
-0.53 (-2.76%)
Nov 22, 2024, 3:56 PM CET
Moberg Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Net Income | -18.25 | -21.09 | -15.71 | 7.49 | 5.87 | 20.03 | Upgrade
|
Depreciation & Amortization | 1.82 | 2.1 | 2.58 | 2.58 | 2.52 | 2.53 | Upgrade
|
Other Amortization | -0.57 | - | - | - | - | - | Upgrade
|
Stock-Based Compensation | 3.91 | 2.31 | 1.46 | 0.63 | 0.95 | 0.91 | Upgrade
|
Other Operating Activities | -4.84 | -4.36 | -3.8 | -27.46 | 2.79 | 4.98 | Upgrade
|
Change in Accounts Receivable | -0.42 | 0.42 | -0.21 | 6.84 | -2.79 | 3.52 | Upgrade
|
Change in Inventory | -6.88 | -7.12 | - | - | - | - | Upgrade
|
Change in Other Net Operating Assets | -2.34 | -5.46 | -1.16 | -4.99 | -18.43 | -28.01 | Upgrade
|
Operating Cash Flow | -27.56 | -33.21 | -16.84 | -15.3 | -10.41 | 3.95 | Upgrade
|
Cash Acquisitions | - | - | - | -10 | -2.51 | -3.76 | Upgrade
|
Sale (Purchase) of Intangibles | -88.24 | -124.12 | -68.07 | -31.31 | -41.42 | -51.26 | Upgrade
|
Investing Cash Flow | -88.24 | -124.12 | -68.07 | -41.31 | -43.93 | -55.02 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 5.09 | Upgrade
|
Total Debt Issued | - | - | - | - | - | 5.09 | Upgrade
|
Long-Term Debt Repaid | - | -2.43 | -1.87 | -3.46 | - | -26.01 | Upgrade
|
Total Debt Repaid | -0.62 | -2.43 | -1.87 | -3.46 | -18.17 | -26.01 | Upgrade
|
Net Debt Issued (Repaid) | -0.62 | -2.43 | -1.87 | -3.46 | -18.17 | -20.92 | Upgrade
|
Issuance of Common Stock | 329.77 | 100.64 | 109.68 | 133.44 | 37.54 | 26.52 | Upgrade
|
Repurchase of Common Stock | -0.19 | -0.19 | - | - | -558.27 | -837.4 | Upgrade
|
Other Financing Activities | -5.7 | -5.7 | - | - | - | - | Upgrade
|
Financing Cash Flow | 323.26 | 92.33 | 107.81 | 129.97 | -538.89 | -831.8 | Upgrade
|
Net Cash Flow | 207.46 | -65 | 22.9 | 73.37 | -593.23 | -882.86 | Upgrade
|
Free Cash Flow | -27.56 | -33.21 | -16.84 | -15.3 | -10.41 | 3.95 | Upgrade
|
Free Cash Flow Margin | -313.75% | - | -8136.23% | - | -30.93% | 7.83% | Upgrade
|
Free Cash Flow Per Share | -0.83 | -2.09 | -2.22 | -3.55 | -5.50 | 2.10 | Upgrade
|
Cash Interest Paid | 0.26 | 0.26 | 0.07 | 0.24 | 2.07 | - | Upgrade
|
Levered Free Cash Flow | -120.82 | -149.44 | -65.28 | 40.32 | - | -57.97 | Upgrade
|
Unlevered Free Cash Flow | -120.68 | -149.28 | -65.24 | 40.4 | - | -57.32 | Upgrade
|
Change in Net Working Capital | 18.98 | 12.13 | -11.62 | -80.83 | - | 26.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.